3 devicemaker acquisitions that could benefit heart patients

Heart disease and strokes kill more than 786,000 Americans each year, according to the American Heart Association. With such a massive need for more treatment options, medical device makers are rolling out new cardiac devices and merging with other companies to improve offerings, reports Mergers & Acquisitions.

Here are three devicemaker acquisitions posed to benefit heart patients.

  1. Irvine, Calif.-based Edwards Lifesciences Corp. announced plans in November to purchase Israel-based Valtech Cardio for $690 million. Through the deal, Edwards Lifesciences will expand its services in heart valve repair and replacement.

2. Minneapolis-based Medtronic acquired HeartWare International for about $1.1 billion in August. Framingham, Mass.-based HeartWare produces miniature implantable heart pumps for patients suffering from advanced heart failure.

3. In December, Wayne, Penn.-based Teleflex purchased Vascular Solutions for about $1 billion. Minneapolis-based Vascular Solutions creates catheters designed to improve vascular procedures.

More articles on supply chain:

AbbVie CEO pledges to rein in price hikes
National Cancer Institute unveils ambitious program to hasten drug research
Op-ed: The 1 way pharma can get on Trump's good side

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>